|
시장보고서
상품코드
2008011
성인용 백신 시장 : 백신 유형별, 기술별, 용도별, 유통 채널별, 지역별Adult Vaccines Market, By Vaccine Type, By Technology, By Application, By Distribution Channel, By Geography |
||||||
성인용 백신 시장은 2026년에 328억 달러로 추정되고 있으며, 2033년까지 516억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.69%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 328억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년의 예측 기간 CAGR : | 6.69% | 2033년 시장 규모 예측 : | 516억 달러 |
예방 의료 시장의 중요한 부문인 글로벌 성인 백신 시장은 18세 이상의 개인에게 예방접종 솔루션 서비스를 제공하는 것을 목표로 하고 있습니다. 이 시장 부문은 백신으로 예방 가능한 질병을 예방하고 의료 비용을 절감하는 데 있으며, 매우 중요한 시장입니다.
성인용 백신은 성인의 질병 발병 위험과 면역 수준에 따라 예방접종 솔루션 서비스를 제공한다는 점에서 다른 백신과 다릅니다. 이 시장 세분화에서는 독감, 폐렴구균, 간염, HPV, 수막염균, 여행용 백신뿐만 아니라 대상포진, RSV 등 새로운 백신을 포함한 다양한 예방접종 솔루션 서비스를 제공하고 있습니다.
의료에 대한 인식 증가, 면역력을 저하시키는 만성질환의 발생률 증가, 보건 당국의 백신 접종 권장 확대 등의 요인이 시장 성장을 촉진하고 있습니다. 또한 COVID-19 팬데믹은 성인용 백신 접종에 대한 인식과 수용성을 높이는 데 일조하며 시장 성장을 더욱 촉진하고 있습니다. 또한 mRNA를 포함한 새로운 백신 기술의 개발로 백신의 효능이 향상될 것으로 예상되며, 이는 시장 성장을 촉진할 것으로 예상됩니다.
시장 역학
세계의 성인용 백신 시장은 성장에 유리한 환경을 조성하는 여러 요인의 영향을 받고 있습니다. 예를 들어 고령화 인구는 독감, 폐렴구균 감염, 대상포진 등 감염성 질환에 걸리기 쉽습니다. 또한 당뇨병과 심장 질환의 증가로 인해 성인은 감염에 더 쉽게 노출되어 있습니다. 의료비 절감과 예방의료를 위한 정부의 노력도 큰 영향을 미치고 있습니다. 또한 국제 여행의 증가와 직장내 건강 프로그램도 백신 수요를 촉진하고 있습니다. 또한 백신 기술의 발전으로 백신의 효능이 향상되어 성인들이 더 쉽게 접종할 수 있게 되었습니다.
그러나 이 시장의 성장을 저해하는 요인으로는 백신에 대한 거부감, 높은 연구개발비, 규제 장벽 등을 들 수 있습니다. 또한 세계 일부 지역의 의료 인프라 미비도 성장에 큰 걸림돌로 작용하고 있습니다.
이러한 도전과제가 있는 반면, 이 시장에는 신흥 시장의 의료 인프라 정비, 가처분 소득 증가, 예방의료 확대 등의 기회가 존재합니다. 예를 들어 혼합백신과 디지털 기술을 통해 백신의 접근성과 유효성이 향상되고 있습니다.
본 조사의 주요 특징.
- 세계의 성인용 백신 시장에 대해 조사분석했으며, 2025년을 기준연도로 하여 예측 기간(2026-2033년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 예측한 보고서입니다.
- 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계의 성인 백신 시장의 주요 기업 개요을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 성인용 백신 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 성인용 백신 시장 : 백신 유형별, 2021-2033년
제5장 세계의 성인용 백신 시장 : 기술별, 2021-2033년
제6장 세계의 성인용 백신 시장 : 용도별, 2021-2033년
제7장 세계의 성인용 백신 시장 : 유통 채널별, 2021-2033년
제8장 세계의 성인용 백신 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 추천
제11장 참고 문헌 및 조사 방법
KSAAdult Vaccines Market is estimated to be valued at USD 32.8 Bn in 2026 and is expected to reach USD 51.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.69% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 32.8 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.69% | 2033 Value Projection: | USD 51.6 Bn |
The global adult vaccines market, being a significant segment of the preventive healthcare market, aims at offering immunization solution services to individuals aged 18 years and above. This market segment is vital in the prevention of vaccine-preventable diseases and the reduction of healthcare costs.
Adult vaccines are different in the sense that they offer immunization solution services to individuals based on the risk of acquiring diseases and immunity levels in adults. This market segment offers various immunization solution services, such as influenza, pneumococcal, hepatitis, HPV, meningococcal, and travel vaccines, among other newer vaccines such as shingles and RSV.
The market growth is driven by factors such as the rising awareness of preventive healthcare, the increasing incidence of chronic diseases which compromise immunity, and the widening recommendations for vaccinations by health authorities. The COVID-19 pandemic has also helped raise the awareness and acceptability of adult vaccination, which is further driving the market growth. In addition, the development of new vaccine technologies, including mRNA, is expected to improve the efficacy of vaccines, thereby driving the market growth.
Market Dynamics
The global adult vaccines market is influenced by a number of factors that create a favorable environment for growth. For instance, an aging population is more susceptible to infections like influenza, pneumococcal disease, and shingles. In addition, an increase in diabetes and heart conditions has made adults more susceptible to infections. Government initiatives aimed at cutting healthcare costs and preventive care are also a major influence. Vaccines are also being driven by an increase in international travel and health programs at the workplace. In addition, advances in vaccine technology are making vaccines more effective and accessible to adults.
However, some factors that inhibit growth in this market are vaccine hesitancy, high R&D costs, and regulatory hurdles. In addition, poor healthcare infrastructure in some parts of the world is a major hindrance to growth.
Despite these challenges, some of the opportunities that are available in this market are a growing healthcare infrastructure in emerging markets, a rise in disposable incomes, and an increase in preventive healthcare. For instance, combination vaccines and digital technologies are making vaccines more accessible and effective.
Key Features of the Study
- This report provides in-depth analysis of the global adult vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global adult vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc, GlaxoSmithKline plc, Merck & Co Inc, Sanofi, Johnson and Johnson, Moderna, AstraZeneca plc, CSL Limited , Serum Institute of India, and Bharat Biotech
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market
Market Segmentation
- Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033)
- Influenza
- Hepatitis
- Human Papillomavirus (HPV)
- Pneumococcal
- Tetanus Diphtheria and Pertussis
- COVID-19
- Others
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Recombinant Vaccines
- mRNA Vaccines
- Toxoid Vaccines
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Preventive
- Therapeutic
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics
- Retail Pharmacies
- Government and Public Health Programs
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc
- GlaxoSmithKline plc
- Merck & Co Inc
- Sanofi
- Johnson and Johnson
- Moderna
- AstraZeneca plc
- CSL Limited
- Serum Institute of India
- Bharat Biotech
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Adult Vaccines Market, By Vaccine Type
- Global Adult Vaccines Market, By Technology
- Global Adult Vaccines Market, By Application
- Global Adult Vaccines Market, By Distribution Channel
- Global Adult Vaccines Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Adult Vaccines Market, By Vaccine Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Human Papillomavirus (HPV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pneumococcal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Tetanus Diphtheria and Pertussis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- COVID-19
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Adult Vaccines Market, By Technology, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Inactivated and Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- mRNA Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Adult Vaccines Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Preventive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Therapeutic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Adult Vaccines Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Government and Public Health Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Adult Vaccines Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Moderna
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CSL Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Serum Institute of India
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
